KIAA1147 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.378600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.885200E-01
Normal-vs-Stage2
2.383600E-01
Normal-vs-Stage3
5.735600E-02
Normal-vs-Stage4
1.761960E-01
Stage1-vs-Stage2
5.650400E-01
Stage1-vs-Stage3
6.848400E-02
Stage1-vs-Stage4
8.033000E-01
Stage2-vs-Stage3
2.297800E-01
Stage2-vs-Stage4
8.519400E-01
Stage3-vs-Stage4
3.115600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.176600E-03
Normal-vs-AfricanAmerican
1.743190E-01
Normal-vs-Asian
2.022400E-01
Caucasian-vs-AfricanAmerican
5.525000E-01
Caucasian-vs-Asian
3.427200E-01
AfricanAmerican-vs-Asian
2.595200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.876000E-03
Normal-vs-Female
4.481100E-03
Male-vs-Female
6.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.391600E-01
Normal-vs-Age(41-60Yrs)
2.622800E-01
Normal-vs-Age(61-80Yrs)
5.122100E-03
Normal-vs-Age(81-100Yrs)
2.010800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.558800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.160200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.715550E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.527400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.270300E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.679030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.371200E-01
Normal-vs-Daily Drinker
5.178700E-03
Normal-vs-Weekly Drinker
2.279600E-02
Normal-vs-Occasional Drinker
2.750500E-02
Normal-vs-Social Drinker
4.412400E-01
Non Drinker-vs-Daily Drinker
6.548400E-01
Non Drinker-vs-Weekly Drinker
5.676200E-01
Non Drinker-vs-Occasional Drinker
6.637000E-01
Non Drinker-vs-Social Drinker
1.106590E-01
Daily Drinker-vs-Weekly Drinker
8.494000E-01
Daily Drinker-vs-Occasional Drinker
4.604200E-01
Daily Drinker-vs-Social Drinker
8.046100E-02
Weekly Drinker-vs-Occasional Drinker
4.489000E-01
Weekly Drinker-vs-Social Drinker
8.597500E-02
Occasional Drinker-vs-Social Drinker
1.856200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.382960E-01
Normal-vs-Grade 2
2.453900E-02
Normal-vs-Grade 3
9.693900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.453600E-01
Grade 1-vs-Grade 3
7.188600E-01
Grade 1-vs-Grade 4
1.382960E-01
Grade 2-vs-Grade 3
6.034800E-01
Grade 2-vs-Grade 4
2.453900E-02
Grade 3-vs-Grade 4
9.693900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.742600E-03
Normal-vs-NonDiabetic
5.118000E-03
Diabetic-vs-NonDiabetic
4.583000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.982400E-02
Normal-vs-NoPancreatitis
4.998100E-03
Pancreatitis-vs-NoPancreatitis
6.444600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.673700E-02
Normal-vs-N1
2.277000E-01
N0-vs-N1
1.546020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.687400E-01
Normal-vs-TP53-NonMutant
1.064210E-01
TP53-Mutant-vs-TP53-NonMutant
2.201600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
